UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report: January 22, 2009
(Date of earliest event reported)
INTUITIVE SURGICAL, INC.
(exact name of registrant as specified in its charter)
Delaware | 000-30713 | 77-0416458 | ||
(State or other jurisdiction of incorporation or organization) |
Commission File Number |
(I.R.S. Employer Identification No.) |
1266 Kifer Road
Sunnyvale, California 94086
(Address of Principal executive offices, including zip code)
(408) 523-2100
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02. | Results of Operations and Financial Condition. |
On January 22, 2009, Intuitive Surgical, Inc. (Intuitive) issued a press release announcing its financial results for the quarter ended December 31, 2008. A copy of the press release is attached hereto as Exhibit 99.1.
The information in this Current Report, including Exhibit 99.1, shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934 (the Exchange Act) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of Intuitive under the Securities Act of 1933 or the Exchange Act.
Item 9.01. | Financial Statements and Exhibits. |
d) Exhibits.
The following exhibit is furnished with this report on Form 8-K:
99.1 | Press release issued by Intuitive Surgical, January 22, 2009. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INTUITIVE SURGICAL, INC. | ||||||||||
Date: January 22, 2009 | By | /s/ Marshall L. Mohr | ||||||||
Name: | Marshall L. Mohr | |||||||||
Title: | Senior Vice President and Chief Financial Officer |
EXHIBIT INDEX
Exhibit No. |
Description | |
99.1 | Press Release issued by Intuitive Surgical, January 22, 2009 |
Exhibit 99.1
FOR IMMEDIATE RELEASE | Contacts: | Ben Gong | 408-523-2175 | |||||
Rae Covington | 408-523-2161 |
INTUITIVE SURGICAL ANNOUNCES FOURTH QUARTER EARNINGS
SUNNYVALE, CALIF. January 22, 2009 Intuitive Surgical, Inc. (NASDAQ: ISRG), the industry leader in surgical robotics, today reported fourth quarter 2008 revenue, consistent with its pre-release of January 7, 2009, of $231.5 million, increasing 22% from $189.4 million for the fourth quarter of 2007. Fourth quarter 2008 revenue growth was driven by continued robotic procedure adoption.
Fourth quarter 2008 instruments and accessories revenue increased 45% to $81.6 million from $56.1 million during the fourth quarter of 2007. Fourth quarter 2008 da Vinci ® Surgical Systems revenue increased 5% to $113.7 million from $108.6 million during the fourth quarter of 2007. Fourth quarter 2008 service revenue increased 46% to $36.2 million from $24.7 million during the fourth quarter of 2007.
Revenue for the year ended December 31, 2008 totaled $874.9 million, increasing 46% from $600.8 million for the year ended December 31, 2007.
Three Months Ended December 31, |
Twelve Months Ended December 31, | |||||||||||||||||
Revenue ($Millions) |
2008 | 2007 | Increase | 2008 | 2007 | Increase | ||||||||||||
Instruments/Accessories |
$ | 81.6 | $ | 56.1 | $ | 25.5 | $ | 293.0 | $ | 191.7 | $ | 101.3 | ||||||
Systems |
113.7 | 108.6 | 5.1 | 455.3 | 324.4 | 130.9 | ||||||||||||
Service |
36.2 | 24.7 | 11.5 | 126.6 | 84.7 | 41.9 | ||||||||||||
$ | 231.5 | $ | 189.4 | $ | 42.1 | $ | 874.9 | $ | 600.8 | $ | 274.1 | |||||||
Fourth quarter 2008 operating income increased 13% to $82.7 million, compared with $73.4 million for the fourth quarter of 2007. Operating results for the fourth quarter of 2008 included $21.4 million of non-cash stock-based compensation expense in accordance with the Financial Accounting Standards Board SFAS 123R, compared with $10.1 million for the fourth quarter of 2007.
Fourth quarter 2008 net income increased 3% to $50.8 million, compared with $49.2 million for the fourth quarter of 2007. Diluted earnings per share increased to $1.27 for the fourth quarter of 2008 from $1.24 for the fourth quarter of 2007.
Net income for the year ended December 31, 2008 was $204.3 million, or $5.12 per diluted share, compared to net income of $144.5 million, or $3.70 per diluted share for the year ended December 31, 2007.
Intuitive ended the fourth quarter of 2008 with cash, cash equivalents and investments of $902 million, up $80 million from September 30, 2008 and up $266 million from December 31, 2007.
Commenting on the announcement, Lonnie Smith, Chairman and CEO of Intuitive Surgical, said, We are pleased with our continued worldwide procedure growth. While our fourth quarter system unit sales were lower than planned, we believe that our procedure momentum remains strong and patient demand for robotic surgery will continue to drive growth in 2009.
The Company will also announce these results at a conference call today at 1:30 pm PDT. The dial-in numbers for the call are 877-909-3508 for participants located in the U.S. and 517-645-6051 for participants located outside the U.S. The passcode is ISRG and the meeting leader is Mr. Lonnie Smith. To access financial information that will be discussed on the call, please visit Intuitive Surgicals website at www.intuitivesurgical.com.
About Intuitives Products:
The da Vinci® Surgical System consists of a surgeons viewing and control console having an integrated, high-performance InSite® 3-D, high definition vision system, a patient-side cart consisting of three or four robotic arms that position and precisely maneuver endoscopic instruments and an endoscope, and a variety of articulating EndoWrist® Instruments. By integrating computer-enhanced technology with surgeons technical skills, Intuitive believes that its system enables surgeons to perform better surgery in a manner never before experienced. The da Vinci® Surgical System seamlessly and directly translates the surgeons natural hand, wrist and finger movements on instrument controls at the surgeons console outside the patients body into corresponding micro-movements of the instrument tips positioned inside the patient through small puncture incisions, or ports.
Intuitive®, da Vinci®, da Vinci® S, InSite®, and EndoWrist® are trademarks or registered trademarks of Intuitive Surgical, Inc.
# # #
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are necessarily estimates reflecting the best judgment of our management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These forward-looking statements should, therefore, be considered in light of various important factors, including the following: the impact of the global economic recession and tightening credit market and related impact on health care spending; timing and success of product development and market acceptance of developed products; regulatory approvals, clearances and restrictions; guidelines and recommendations in the health care and patient communities; intellectual property positions and litigation; competition in the medical device industry and in the specific markets of surgery in which Intuitive Surgical operates; unanticipated manufacturing disruptions; delays in regulatory approvals of new manufacturing facilities or the inability to meet demand for products, the results of the year end audit, and the other factors detailed from time to time under the heading Risk Factors in our report on Form 10-K for the year ended December 31, 2007, as updated from time to time by our quarterly reports on Form 10-Q and our other filings with the Securities and Exchange Commission. Statements concerning forecasts, revenue growth, procedure growth, future financial results, and statements using words such as estimate, project, plan, intend, expect, anticipate, believe and similar expressions are intended to identify forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. We undertake no obligation to publicly update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.
INTUITIVE SURGICAL, INC.
UNAUDITED QUARTERLY CONSOLIDATED STATEMENTS OF INCOME
(IN THOUSANDS, EXCEPT PER SHARE DATA)
Three months ended | |||||||||
December 31, 2008 |
September 30, 2008 |
December 31, 2007 | |||||||
Revenue: |
|||||||||
Instruments & Accessories |
$ | 81,575 | $ | 75,941 | $ | 56,095 | |||
Systems |
113,752 | 126,326 | 108,607 | ||||||
Services |
36,218 | 33,725 | 24,744 | ||||||
Total revenue |
231,545 | 235,992 | 189,446 | ||||||
Cost of revenue: |
|||||||||
Products |
51,669 | 53,517 | 42,587 | ||||||
Services |
14,536 | 12,900 | 11,659 | ||||||
Total cost of revenue (1) |
66,205 | 66,417 | 54,246 | ||||||
Gross profit |
165,340 | 169,575 | 135,200 | ||||||
Operating expenses: |
|||||||||
Selling, general and administrative |
61,739 | 62,692 | 45,694 | ||||||
Research and development (2) |
20,864 | 21,851 | 16,124 | ||||||
Total operating expenses (1) |
82,603 | 84,543 | 61,818 | ||||||
Income from operations |
82,737 | 85,032 | 73,382 | ||||||
Interest and other income, net |
5,525 | 4,594 | 8,432 | ||||||
Income before income taxes |
88,262 | 89,626 | 81,814 | ||||||
Provision for income taxes |
37,504 | 32,032 | 32,660 | ||||||
Net lncome |
$ | 50,758 | $ | 57,594 | $ | 49,154 | |||
Earnings per share: |
|||||||||
Basic |
$ | 1.30 | $ | 1.48 | $ | 1.28 | |||
Diluted |
$ | 1.27 | $ | 1.44 | $ | 1.24 | |||
Shares used in computing earnings per share: |
|||||||||
Basic |
39,138 | 39,015 | 38,364 | ||||||
Diluted |
39,837 | 40,108 | 39,756 | ||||||
(1) | Includes stock compensation expense of $3.1 million, $3.1 million and $1.6 million in total cost of revenue and $18.3 million, $17.9 million and $8.5 million in total operating expenses for the three months ended December 31, 2008, September 30, 2008 and December 31, 2007, respectively. |
(2) | Includes amortization of purchased intellectual property of $3.4 million, $2.7 million and $0.5 million in research and development expenses for the three months ended December 31, 2008, September 30, 2008 and December 31, 2007, respectively. |
INTUITIVE SURGICAL, INC.
UNAUDITED ANNUAL CONSOLIDATED STATEMENTS OF INCOME
(IN THOUSANDS, EXCEPT PER SHARE DATA)
Year ended December 31, | ||||||
2008 | 2007 | |||||
Revenue: |
||||||
Instruments & Accessories |
$ | 292,989 | $ | 191,651 | ||
Systems |
455,336 | 324,438 | ||||
Services |
126,594 | 84,739 | ||||
Total revenue |
874,919 | 600,828 | ||||
Cost of revenue: |
||||||
Products |
200,074 | 145,654 | ||||
Services |
54,068 | 40,888 | ||||
Total cost of revenue (1) |
254,142 | 186,542 | ||||
Gross profit |
620,777 | 414,286 | ||||
Operating expenses: |
||||||
Selling, general and administrative |
230,570 | 158,685 | ||||
Research and development (2) |
79,372 | 48,859 | ||||
Total operating expenses (1) |
309,942 | 207,544 | ||||
Income from operations |
310,835 | 206,742 | ||||
Interest and other income, net |
24,368 | 30,492 | ||||
Income before income taxes |
335,203 | 237,234 | ||||
Provision for income taxes |
130,888 | 92,697 | ||||
Net lncome |
$ | 204,315 | $ | 144,537 | ||
Earnings per share: |
||||||
Basic |
$ | 5.26 | $ | 3.82 | ||
Diluted |
$ | 5.12 | $ | 3.70 | ||
Shares used in computing earnings per share: |
||||||
Basic |
38,877 | 37,831 | ||||
Diluted |
39,943 | 39,021 | ||||
(1) | Includes stock compensation expense of $11.4 million and $5.8 million in total cost of revenue and $65.3 million and $30.5 million in total operating expenses for the year ended December 31, 2008 and 2007, respectively. |
(2) | Includes amortization of purchased intellectual property of $9.8 million and $1.3 million in research and development expenses for the year ended December 31, 2008 and 2007, respectively. |
INTUITIVE SURGICAL, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS)
12/31/2008 | 9/30/2008 | 12/31/07 | |||||||
Cash, cash equivalents, and investments |
$ | 901,873 | $ | 821,431 | $ | 635,381 | |||
Accounts receivable, net |
170,107 | 173,708 | 130,370 | ||||||
Inventory |
63,460 | 52,498 | 32,416 | ||||||
Property and equipment, net |
117,021 | 98,081 | 68,093 | ||||||
Goodwill |
110,740 | 110,740 | 110,740 | ||||||
Deferred tax assets |
45,357 | 38,973 | 24,577 | ||||||
Other assets |
66,066 | 69,240 | 38,421 | ||||||
Total assets |
$ | 1,474,624 | $ | 1,364,671 | $ | 1,039,998 | |||
Accounts payable and other accrued liabilities |
$ | 128,606 | $ | 108,442 | $ | 96,632 | |||
Deferred revenue |
79,252 | 72,801 | 54,692 | ||||||
Total liabilities |
207,858 | 181,243 | 151,324 | ||||||
Stockholders equity |
1,266,766 | 1,183,428 | 888,674 | ||||||
Total liabilities and stockholders equity |
$ | 1,474,624 | $ | 1,364,671 | $ | 1,039,998 | |||